Analysed RANI THERAPEUTICS HOLDINGS-A (RANI:NASDAQ) News Sources
Companies Like Rani Therapeutics Holdings (NASDAQ:RANI) Are In A Position To Invest In Growth
28-03-2026
yahoo.com
Rani Therapeutics Appoints Dr. Sara Kenkare-Mitra as Strategic Advisor to Advance Platform and Clinical Strategy
09-04-2026
yahoo.com
This Rani Therapeutics Holdings Insider Increased Their Holding By 9,754% Last Year
08-05-2026
yahoo.com
Rani Therapeutics to Participate in the H.C. Wainwright Annual BioConnect Investor Conference
12-05-2026
yahoo.com
Rani Therapeutics Reports First Quarter 2026 Financial Results; Provides Corporate Update; Announces CFO Transition
15-05-2026
yahoo.com
Rani Therapeutics Holdings, Inc. Announces Pricing of $20.0 Million Registered Direct Offering of Class A Common Stock Priced At-The-Market Under Nasdaq Rules
26-05-2026
yahoo.com
Rani Therapeutics Announces Research and Development Collaboration with PegBio to Expand Obesity Pipeline Across Multiple Novel Candidates
09-07-2026
yahoo.com
What is the current price of RANI THERAPEUTICS HOLDINGS-A (RANI:NASDAQ)?
The current price of RANI THERAPEUTICS HOLDINGS-A (RANI:NASDAQ) is $0.6699.
RANI THERAPEUTICS HOLDINGS-A (RANI:NASDAQ) absolute price change since previous trading day?
The absolute price change of RANI THERAPEUTICS HOLDINGS-A (RANI:NASDAQ) since the previous trading day is $-0.0071.
RANI THERAPEUTICS HOLDINGS-A (RANI:NASDAQ) percentage price change since previous trading day?
The percentage price change of RANI THERAPEUTICS HOLDINGS-A (RANI:NASDAQ) since the previous trading day is -1.0487%.
What is the most recent average sentiment score for RANI THERAPEUTICS HOLDINGS-A (RANI:NASDAQ)?
The most recent average sentiment score for RANI THERAPEUTICS HOLDINGS-A (RANI:NASDAQ) is 88 out of 100.
What is the most recent average sentiment for RANI THERAPEUTICS HOLDINGS-A (RANI:NASDAQ)?
The most recent sentiment for RANI THERAPEUTICS HOLDINGS-A (RANI:NASDAQ) is .
SEC-8K** Filing Available For RANI THERAPEUTICS HOLDINGS-A (RANI:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.